Sex Differences in the Beneficial Cardiac Effects of Chronic Treatment with Atrial Natriuretic Peptide In Spontaneously Hypertensive Rats

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Romero, Mariana ^a   Caniffi, Carolina ^a   Bouchet, Gonzalo ^a   Elesgaray, Rosana ^a   Laughlin, Myriam Mac ^a   Tomat, Analía ^a   Arranz, Cristina ^a   Costa, Maria A ^a  

^a Universidad de Buenos Aires   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CATALASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; HEART INJURY; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HYPERTENSION; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; SEX DIFFERENCE; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; APOPTOSIS; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; CATALASE; DISEASE MODELS, ANIMAL; FEMALE; GLUTATHIONE; HEART; HYPERTENSION; MALE; MYOCARDIUM; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; RATS, INBRED SHR; SEX FACTORS; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA;

EID: 84881530794     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071992     Document Type: Article

References (55)

1. Reckelhoff JF, (2001) Gender difference in the regulation of blood pressure. Hypertension 35: 1199-1208.
2. Félétou M, Vanhoutte PM, (2006) Endothelial dysfunction: a multifaceted disorder. Am J Physiol Heart Circ Physiol 291(3): H985-H1002.
3. Leskinen H, Vuolteenaho O, Toth M, Ruskoaho H, (1997) Atrial natriuretic peptide inhibits its own secretion via ANP(A) receptors: altered effect in experimental hypertension. Endocrinology 138(5): 1893-902.
4. Reckelhoff JF, Zhang H, Granger JP, (1998) Testosterone exacerbates hypertension and reduces pressure-natriuresis in male spontaneously hypertensive rats. Hypertension 31: 435-439.
5. Capek P, Brdicka R, (2006) Hypertrophic cardiomyopathy. Cas Lek Cesk 145: 93-6.
6. Chan V, Fenning A, Levick SP, Loch D, Chunduri P, et al. (2011) Cardiovascular changes during maturation and ageing in male and female spontaneously hypertensive rats. J Cardiovasc Pharmacol 57(4): 469-78.
7. Zhang F, Ram JL, Standley PR, Sowers JR, (1994) 17 beta-Estradiol attenuates voltage-dependent Ca2+ currents in A7r5 vascular smooth muscle cell line. Am J Physiol 266: 975-80.
8. Brosnihan KB, Moriguchi A, Nakamoto H, Dean RH, Ganten D, et al. (1994) Estrogen augments the contribution of nitric oxide to blood pressure regulation in transgenic hypertensive rats expressing the mouse Ren-2 gene. Am J Hypertens 7: 576-82.
9. Huang A, Sun D, Koller A, Kaley G, (1998) Gender difference in flow-induced dilation and regulation of shear stress: role of estrogen and nitric oxide. Am J Physiol 275(5 Pt 2): R1571-7.
10. Belo NO, Silva-Barra J, Carnio EC, Antunes-Rodrigues J, Gutkowska J, et al. (2004) Involvement of atrial natriuretic peptide in blood pressure reduction induced by estradiol in spontaneously hypertensive rats. Regul Pept 117(1): 53-60.
11. Clerico A, Iervasi G, Del Chicca MG, Emdin M, Maffei S, et al. (1998) Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure. J Endocrinol Invest 21: 170-179.
12. Jensen KT, Carstens J, Ivarsen P, Pedersen EB, (1997) A new, fast, and reliable radioimmunoassay of brain natriuretic peptide in human plasma; reference values in healthy subjects and in patients with different diseases. Scand J Clin Lab Invest 57: 529-540.
13. Costa MA, Gonzalez Bosc LV, Majowicz MP, Vidal NA, Balaszczuk AM, et al. (2000) Atrial natriuretic peptide modifies arterial blood pressure through nitric oxide pathway in rats. Hypertension 35: 1119-23.
14. Costa MA, Elesgaray R, Loria A, Balaszczuk AM, Arranz C, (2004) Atrial natriuretic peptide influence on nitric oxide system in kidney and heart. Regul Pept 118(3): 151-157.
15. Costa MA, Elesgaray R, Caniffi C, Rodríguez Ierase D, Fellet A, et al. (2010) Role of nitric oxide as a key mediator on cardiovascular actions of atrial natriuretic peptide in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 298(3): H778-86.
16. Rakhit RD, Marber MS, (2001) Nitric oxide: an emerging role in cardioprotection? Heart 86: 368-72.
17. Chang T, Wu L, (2006) Methylglyoxal, oxidative stress, and hypertension. Can J Physiol Pharmacol 84(12): 1229-38.
18. Shono M, Yoshimura M, Nakayama M, Yamamuro M, Abe K, et al. (2007) Predominant effect of A-type natriuretic peptide on reduction of oxidative stress during treatment of patients with heart failure. Circ J 71: 1040-6.
19. De Vito P, Incerpi S, Pedersen JZ, Luly P, (2010) Atrial natriuretic peptide and oxidative stress. Peptides 31: 1412-1419.
20. Laskowski A, Woodman OL, Cao AH, Drummond GR, Marshall T, et al. (2006) Antioxidant actions contribute to the antihypertrophic effects of atrial natriuretic peptide in neonatal rat cardiomyocytes. Cardiovasc Res 72: 112-23.
21. Zhu Y, Bian Z, Lu P, Karas RH, Bao L, et al. (2002) Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science 295: 505-508.
22. Wassman S, Baumer AT, Strehlow K, van Eickel M, Grohè C, et al. (2001) Endothelial dysfunction and oxidative stress during estrogen deficiency in spontaneously hypertensive rats. Circulation 103: 435-441.
23. Verdon CP, Burton BA, Prior RL, (1995) Sample pre-treatment with nitrate reductase and glucose-6-phosfate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP+ when the Griess reaction is used to assay for nitrite. Anal Biochem 224: 502-508.
24. Costa MA, Loria A, Elesgaray R, Balaszczuk AM, Arranz C, (2004) Role of nitric oxide pathway in hypotensive and renal effects of furosemide during extracellular volume expansion. J Hypertens 22: 1-9.
25. Costa MA, Elesgaray R, Loria A, Balaszczuk AM, Arranz C, (2006) Vascular and renal effects of dopamine during extracellular volume expansion: role of nitric oxide pathway. Life Sci 78: 1543-1549.
26. Buege JA, Aust SD, (1978) Microsomal lipid peroxidation. Methods Enzymol 52: 302-310.
27. Misra HP, Fridovich I, (1972) The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Bio Chem 247: 3170-3175.
28. Maehly AC, Chance B, (1954) The assay of catalases and peroxidases. Methods Biochem Anal 1: 357-424.
29. Flohé L, Gunzler A, (1984) Assays of glutathione peroxidase. Methods Enzymol 105: 114-121.
30. Tietze F, (1959) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 27: 502-522.
31. Bradford MM, (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
32. Tomat AL, Costa MA, Girgulsky LC, Veiras L, Weisstaub AR, et al. (2007) Zinc defienciency during growth: influence on renal function and morphology. Life Sci 80: 1292-1302.
33. Elesgaray R, Caniffi C, Savignano L, Romero M, Mac Laughlin M, et al. (2012) Renal actions of atrial natriuretic peptide in spontaneously hypertensive rats: the role of nitric oxide as a key mediator. Am J Physiol Renal Physiol 302(11): F1385-94.
34. Hall JE, Granger JP, Reckelhoff JF, Sandberg K, (2008) Hypertension and cardiovascular Disease in Women. Hypertension 51(4): 951.
35. Brosnihan KB, Moriguchi A, Nakamoto H, Dean RH, Ganten D, et al. (1994) Estrogen augments the contribution of nitric oxide to blood pressure regulation in transgenic hypertensive rats expressing the mouse Ren-2 gene. Am J Hypertens 7(7Pt 1): 576-82.
36. Huang A, Sun D, Kaley G, Koller A, (1997) Estrogen maintains nitric oxide synthesis in arterioles of female hypertensive rats. Hypertension 29(6): 1351-6.
37. Yang S, Bae L, Zhang L, (2000) Estrogen increases eNOS and NOx release in human coronary artery endothelium. Cardiovasc Pharmacol 36(2): 242-7.
38. Mendelsohn ME, Karas RH, (1999) The protective effects of estrogen on the cardiovascular system. N Engl J Med 340: 1801-1811.
39. Brandes RP, Mugge A, (1997) Gender differences in the generation of superoxide anions in the rat aorta. Life Sci 60: 391-396.
40. Dantas AP, Franco MC, Silva-Antonialli MM, Tostes RC, Fortes ZB, et al. (2004) Gender differences in superoxide generation in microvessels of hypertensive rats: role of NAD(P)H-oxidase. CardiovascRes 61: 22-29.
41. Lacy F, Kailasam MT, O'Conner DT, Schmid-Schonbein GW, Parmer RJ, (2000) Plasma hydrogen peroxide production in human essential hypertension. Role of heredity, gender and ethnicity. Hypertension 36: 878-884.
42. Barp J, Araujo AS, Fernandes TR, Rigatto KV, Llesuy S, et al. (2002) Myocardial antioxidants and oxidative stress changes due to sex hormones. Braz J Med Biol Res 35: 1075-1081.
43. Álvarez MC, Caldiz C, Fantinelli JC, Garciarena CD, Console GM, et al. (2008) Is cardiac hypertrophy in spontaneously hypertensive rats the cause or the consequence of oxidative stress? Hypertens Res 31: 1465-1476.
44. Pedram A, Razandi M, O'Mahony F, Lubahn D, Levin ER, (2010) Estrogen receptor-beta prevents cardiac fibrosis. Mol Endocrinol 24(11): 2152-65.
45. Diez J, Panizo A, Hernández M, Vega F, Sola I, et al. (1997) Cardiomyocyte apoptosis and cardiac angiotensin-converting enzyme in spontaneously hypertensive rats. Hypertension 30: 1029-1034.
46. Pelzer T, Schumann M, Neumann M, Jager T, Stimpel M, et al. (2000) 17 beta-estradiol prevents programmed cell death in cardiac myocytes. Biochem Biophys Res Comm 268: 192-200.
47. Bilzer M, Jaeschke H, Vollmar AM, Paumgartner G, Gerbes AL, (1999) Prevention of Kupffer cell-induced oxidant injury in rat liver by atrial natriuretic peptide. Am J Physiol 276(5 Pt 1): G1137-44.
48. Saha S, Li Y, Lappas G, Anand-Srivastava MB, (2008) Activation of natriuretic peptide receptor-C attenuates the enhanced oxidative stress in vascular smooth muscle cells from spontaneously hypertensive rats: implication of Gi alpha protein. J Mol Cell Cardiol 44: 336-344.
49. Shono M, Yoshimura M, Nakayama M, Yamamuro M, Abe K, et al. (2007) Predominant effect of A-type natriuretic peptide on reduction of oxidative stress during the treatment of patients with heart failure. Circ J 71: 1040-1046.
50. Potter LR, Yoder AR, Flora DR, Antos LK, Dickey MD, (2009) Natriuretic peptides: Structures, receptors, physiologic functions and therapeutic applications. Handb Exp Pharmacol 191: 341-66.
51. Oliver PM, Fox JE, Kim R, Rockman HA, Kim HS, et al. (1997) Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci 94: 14730-14735.
52. Wu CF, Bishoprici NH, Pratt RE, (1997) Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes. J Biol Chem 27223(6): 14860-14866.
53. Kato T, Muraski J, Chen J, Tsujita Y, Wall J, et al. (2005) Atrial natriuretic peptide promotes cardiomyocyte survival by cGMP-dependent nuclear accumulation of zyxin and Akt. J Clin Invest 115: 2716-2730.
54. Chang HR, Wu CY, Hsu YH, Chen HI, (2005) Reduction of ventricular hypertrophy and fibrosis in spontaneously hypertensive rats by L-arginine. Chinese J Physiol 48: 15-22.
55. Smith RS Jr, Agata J, Xia CF, Chao L, Chao J, (2005) Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction. Life Sci 876(21): 2457-71.